Dependence on New and Enhanced Products and Seasonal Fluctuations in Sales and Profit
First written in FY2016. 11 of 30 entries say "Restated". Latest entry: FY2026.
Ivy Cosmetics moved to the "Worse" side of this theme in 2017, 7 years before the typical company in this theme (2024).
The whole theme swung hardest in 2024: 4 of 13 companies on the "Worse" side.
1 other company's latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「New and enhanced products accounted for 49.8% of our revenue in the fiscal year ended March 2024, 47.3% in the fiscal year ended March 2025 and 37.4% in the fiscal year ending March 2026,」
Dependence on new and enhanced products declined from 47.3% to 37.4%. The disclosure states that seasonal fluctuations and the impact of product sales performance on business results nevertheless remain. - FY2025WorsenedAnnual report
「New and enhanced products accounted for 44.9% of our revenue in the fiscal year ended March 2023, 49.8% in the fiscal year ended March 2024 and 47.3% in the fiscal year ended March 2025. As shown in the table below, revenue has historically been highly seasonal and has tended to be concentrated in certain periods due to the timing of promotional campaigns for new and enhanced products.」
Dependence on new and enhanced products increased from 19.1% in the previous fiscal year to 49.8% and 47.3%, and both dependence and seasonal volatility rose again. - FY2025-H1MaterialisedAnnual report
「Although orders for the newly launched beauty supplement Euglena Vital EX in June 2024 were in line with initial expectations, they were below the order value for new products in the previous interim period, resulting in a decline in total revenue.」
Orders for the new product were below those for new products in the previous interim period, and total revenue fell 7.8% year on year. Revenue volatility driven by new-product performance has materialized in the results. - FY2024Lower dependence alongside the core product falling short of its targetAnnual report
「New and enhanced products accounted for 51.5% of our revenue in the fiscal year ended March 2022, 44.9% in the fiscal year ended March 2023 and 19.1% in the fiscal year ended March 2024. As shown in the table below, revenue has historically been highly seasonal and has tended to be concentrated in certain periods due to the timing of promotional campaigns for new and enhanced products.」
Although dependence on new and enhanced products declined to 19.1%, the core serum falling short of its target affected full-year revenue, and volatility related to the product and timing remains. - FY2024-Q3MaterialisedAnnual report
「Meanwhile, partly because organizational activity declined due to the extreme heat that continued from July through September, shipments of Red Power Serum, one of our core products, totaled 14,964 sets in the first nine months, below the 17,470 sets shipped in the same period of the previous year, indicating weak performance.」
Seasonally driven weakness in organizational activity and lower shipments of the core serum materialized as revenue volatility affected by the product and timing. - FY2024-Q1RestatedAnnual report
「Our quarterly revenue and other measures are highly volatile, and performance tends to be sluggish in the first quarter each year.」
The seasonal pattern of first-quarter revenue and profit or loss tending to be sluggish is reaffirmed. - FY2023MitigatedAnnual report
「New and enhanced products accounted for 55.5% of our revenue in the fiscal year ended March 2021, 51.5% in the fiscal year ended March 2022 and 44.9% in the fiscal year ended March 2023. As shown in the table below, revenue has historically been highly seasonal and has tended to be concentrated in certain periods due to the timing of promotional campaigns for new and enhanced products.」
Dependence on new and enhanced products declined from 55.5% and 51.5% to 44.9%, but the impact of seasonal fluctuations and product performance on business results continues to be described. - FY2023-Q3RestatedAnnual report
「Because revenue is generated primarily during the second and fourth quarters, revenue in the first and third quarters is normally significantly lower than in the other quarters.」
The notes reaffirm that revenue is concentrated in the second and fourth quarters and low in the first and third quarters. - FY2023-Q1RestatedAnnual report
「Our quarterly revenue and other measures are highly volatile, and performance tends to be sluggish in the first quarter each year.」
The continuing seasonal pattern of first-quarter revenue and profit or loss tending to be sluggish is described. - FY2022MaterialisedAnnual report
「New and enhanced products accounted for 38.2% of our revenue in the fiscal year ended March 2020, 55.5% in the fiscal year ended March 2021 and 51.5% in the fiscal year ended March 2022. As shown in the table below, revenue has historically been highly seasonal and has tended to be concentrated in certain periods due to the timing of promotional campaigns for new and enhanced products.」
Dependence declined from 55.5% in the previous fiscal year to 51.5% but remained high, while new and enhanced product sales falling short of expectations affected actual business performance. - FY2022-Q2RestatedAnnual report
「Because revenue is generated primarily during the second and fourth quarters, revenue for the first six months is normally significantly higher than twice the revenue generated in the first quarter.」
The seasonal pattern of revenue being concentrated in the second and fourth quarters is reaffirmed. - FY2021WorsenedAnnual report
「New and enhanced products accounted for approximately 21.0% of our revenue in the fiscal year ended March 2019, 38.2% in the fiscal year ended March 2020 and 55.5% in the fiscal year ended March 2021,」
Dependence on new and enhanced products increased from 21.0% to 38.2% and 55.5%, indicating that dependence has risen again. - FY2021-Q3RestatedAnnual report
「Because revenue is generated primarily during the second and fourth quarters, revenue in the first and third quarters is normally significantly lower than in the other quarters.」
The seasonal pattern of revenue being concentrated in the second and fourth quarters and low in the first and third quarters is reaffirmed. - FY2021-Q1RestatedAnnual report
「Because we formulate our sales plan to concentrate shipments to distributors mainly in the autumn and spring, revenue for the first quarter is normally significantly lower than in the other quarters. Operating income, ordinary income and quarterly net income are also normally significantly lower in the first quarter than in the other quarters because operating expenses do not fluctuate as much as revenue, resulting in a cost structure that makes losses more likely to be recorded.」
The seasonal pattern of shipments being concentrated in the autumn and spring, with low first-quarter revenue and a greater likelihood of recording a loss, is reaffirmed. - FY2020-Q3RestatedAnnual report
「Because revenue is generated primarily during the second and fourth quarters, revenue in the first and third quarters is normally significantly lower than in the other quarters.」
The seasonal pattern of revenue being concentrated in the second and fourth quarters and low in the first and third quarters is reaffirmed. - FY2020-Q1MaterialisedAnnual report
「Meanwhile, partly because the sales budget for new products was lower than in the same quarter of the previous year, revenue from new products fell 74.1% year on year. As a result, total revenue declined 21.0% year on year.」
The substantial decline in new-product revenue materialized as a 21.0% decline in total revenue, demonstrating the actual revenue volatility associated with new-product performance. - FY2019MitigatedAnnual report
「New and enhanced products accounted for approximately 67.4% of our revenue in the fiscal year ended March 2018 and approximately 21.0% in the fiscal year ended March 2019,」
Dependence on new and enhanced products declined from approximately 67.4% to approximately 21.0%. However, weak orders for the core serum continued to affect business performance. - FY2019-Q3WorsenedAnnual report
「The substantial decline in revenue was mainly attributable to inventory adjustments by distributors for the enhanced product Red Power Serum, which fell 84.3% from the cumulative third-quarter period of the previous year,」
The 84.3% year-on-year decline in the core enhanced product was explicitly stated, further highlighting revenue volatility arising from dependence on enhanced products and inventory adjustments. - FY2019-Q2WorsenedAnnual report
「Because this product accounted for a high 75% of the sales budget, revenue declined substantially.」
Dependence on Red Power Serum was explicitly stated at 75% of the sales budget, and weak orders for the product materialized as a substantial revenue decline. - FY2019-Q1RestatedAnnual report
「Because revenue is generated primarily during the second and fourth quarters, revenue in the first and third quarters is normally significantly lower than in the other quarters.」
The seasonal pattern of revenue being low in the first and third quarters and concentrated in the second and fourth quarters is reaffirmed. - FY2018MaterialisedAnnual report
「New and enhanced products accounted for approximately 67.4% of our Group's revenue in the fiscal year ended March 2018. As shown in the table below, revenue has historically been highly seasonal and has tended to be concentrated in certain periods due to the timing of promotional campaigns for new and enhanced products. Accordingly, our business performance may be affected by sales of new and enhanced products under promotional campaigns.」
Dependence on new and enhanced products remained high at approximately 67.4%, while weak orders for Red Power Serum and White Power Serum materialized as lower revenue and a loss. - FY2018-Q3MaterialisedAnnual report
「Although revenue from regular products increased 51% year on year in October–December 2017, revenue for the first nine months declined year on year because the substantial decrease in revenue during the first six months had a significant impact, the number of active sales personnel did not reach the initial plan, and additional orders for Red Power Serum during the first nine months decreased from the same period of the previous year.」
Lower additional orders for Red Power Serum and the shortfall in the planned number of active sales personnel materialized as a decline in cumulative revenue, which fell 20.6% year on year. - FY2018-Q2MaterialisedAnnual report
「Initial orders for Red Power Serum during the fiscal year were approximately 360,000 units, below expectations due to subdued performance, and revenue for the quarter declined year on year.」
Suppressed orders for existing enhanced products due to expectations for new products, together with sales falling short of expectations, materialized as a revenue decline in the quarter. - FY2018-Q1RestatedAnnual report
「Because revenue is generated primarily during the second and fourth quarters, revenue in the first and third quarters is normally significantly lower than in the other quarters.」
The notes reaffirm that revenue is low in the first and third quarters and concentrated in the second and fourth quarters. - FY2017WorsenedAnnual report
「New and enhanced products accounted for approximately 71% of our Group's revenue in the fiscal year ended March 2017. As shown in the table below, revenue has historically been highly seasonal and has tended to be concentrated in certain periods due to the timing of promotional campaigns for new and enhanced products.」
Dependence on new and enhanced products increased from approximately 48% in the fiscal year ended March 2016 to approximately 71% in the fiscal year ended March 2017. - FY2017-Q2RestatedAnnual report
「Because revenue is generated primarily during the second and fourth quarters, revenue for the first six months is normally significantly higher than twice the revenue generated in the first quarter.」
The seasonal pattern of revenue being concentrated in the second and fourth quarters continues to be described. - FY2017-Q1RestatedAnnual report
「Because revenue is generated primarily during the second and fourth quarters, revenue in the first and third quarters is normally significantly lower than in the other quarters.」
Revenue is concentrated in the second and fourth quarters, while revenue in the first and third quarters is significantly lower, clearly indicating seasonal fluctuations. - FY2016First statedAnnual report
「New and enhanced products accounted for approximately 48% of our Group's revenue in the fiscal year ended March 2016. As shown in the table below, revenue has historically been highly seasonal and has tended to be concentrated in certain periods due to the timing of promotional campaigns for new and enhanced products.」
New and enhanced products accounted for approximately 48% of revenue, with seasonal fluctuations related to the timing of promotional campaigns identified as a business risk.